Neumora Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.83-$21 |
Market Cap | $416.8M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.20 |
News
See moreYahoo Finance • 7 months ago
Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation
Yahoo Finance • last year
Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study
Yahoo Finance • last year
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
Yahoo Finance • last year
Neumora Therapeutics to Participate in Upcoming Conferences in November
About
CEO | Mr. Henry O. Gosebruch |
Address | 490 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 124 |
